Evidence map›Paper›PMID 28320932›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Data-based modeling of drug penetration relates human skin barrier function to the interplay of diffusivity and free-energy profiles.

Robert Schulz, Kenji Yamamoto, André Klossek, Roman Flesch, Stefan Hönzke, Fiorenza Rancan, Annika Vogt, Ulrike Blume-Peytavi, Sarah Hedtrich, Monika Schäfer-Korting and 2 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 52 citations in OpenAlex.

  1. Scanning Transmission Soft X-Ray Microscopy Probes Topical Drug Delivery of Rapamycin Facilitated by Microneedles.Chemphyschem : a European journal of chemical physics and physical chemistry · 2025
    Article
  2. Article
  3. Visualization of Nanocarriers and Drugs in Cells and Tissue.Handbook of experimental pharmacology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Robert SchulzDepartment of Physics, Freie Universität Berlin, 14195 Berlin, Germany.
Kenji YamamotoPhysical Chemistry, Freie Universität Berlin, 14195 Berlin, Germany.
André KlossekPhysical Chemistry, Freie Universität Berlin, 14195 Berlin, Germany.
Roman FleschPhysical Chemistry, Freie Universität Berlin, 14195 Berlin, Germany.
Stefan HönzkeInstitute of Pharmacy, Freie Universität Berlin, 14195 Berlin, Germany.
Fiorenza RancanClinical Research Center for Hair and Skin Science, Charité Clinic, 10117 Berlin, Germany.
Annika VogtClinical Research Center for Hair and Skin Science, Charité Clinic, 10117 Berlin, Germany.
Ulrike Blume-PeytaviClinical Research Center for Hair and Skin Science, Charité Clinic, 10117 Berlin, Germany.
Sarah HedtrichInstitute of Pharmacy, Freie Universität Berlin, 14195 Berlin, Germany.
Monika Schäfer-KortingInstitute of Pharmacy, Freie Universität Berlin, 14195 Berlin, Germany.
Eckart RühlPhysical Chemistry, Freie Universität Berlin, 14195 Berlin, Germany.
Roland R NetzDepartment of Physics, Freie Universität Berlin, 14195 Berlin, Germany; rnetz@physik.fu-berlin.de.
Freie Universität Berlin · DECharité - Universitätsmedizin Berlin · DEClinical Research Center for Hair and Skin Science · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Based on experimental concentration depth profiles of the antiinflammatory drug dexamethasone in human skin, we model the time-dependent drug penetration by the 1D general diffusion equation that accounts for spatial variations in the diffusivity and free energy. For this, we numerically invert the diffusion equation and thereby obtain the diffusivity and the free-energy profiles of the drug as a function of skin depth without further model assumptions. As the only input, drug concentration profiles derived from X-ray microscopy at three consecutive times are used. For dexamethasone, skin barrier function is shown to rely on the combination of a substantially reduced drug diffusivity in the stratum corneum (the outermost epidermal layer), dominant at short times, and a pronounced free-energy barrier at the transition from the epidermis to the dermis underneath, which determines the drug distribution in the long-time limit. Our modeling approach, which is generally applicable to all kinds of barriers and diffusors, allows us to disentangle diffusivity from free-energetic effects. Thereby we can predict short-time drug penetration, where experimental measurements are not feasible, as well as long-time permeation, where ex vivo samples deteriorate, and thus span the entire timescales of biological barrier functioning.

Indexed as

Administration, CutaneousDexamethasoneDiffusionEpidermisHumansMicroscopyModels, ChemicalSkin AbsorptionX-RaysDexamethasonebiological barriersdata-based modelingdiffusionskinSmoluchowski equation

Identifiers

PMID28320932
PMCPMC5389326
OpenAlexW2601730290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.